Global Pharmacovigilance Market Key Insights 2023-2032
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
According to The Business Research Company’s Pharmacovigilance Global Market Report 2023, the pharmacovigilance market is expected to show promising growth in the forecast period.
Five Key insights from the forecast include:
- Market Size – The global pharmacovigilance market size is expected to grow from $6.66 billion in 2022 to $7.62 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. The pharmacovigilance market size is expected to grow to $11.98 billion in 2027 at a CAGR of 12.0%.
- Major Driver – The Rise In Number Of Adverse Medication Reactions is projected to move the pharmacovigilance market ahead.
- Key Trend – Technological improvements have emerged as a prominent trend in the pharmacovigilance industry. Many pharmacovigilance firms are implementing advanced technical solutions, like as artificial intelligence (AI), to reduce cycle time, improve quality and accuracy, provide scalable and futuristic solutions, increase productivity, and improve compliance.
- Largest Region – North America was the largest region in the pharmacovigilance market in 2022.
- Major Players – Major players in the pharmacovigilance market are Accenture, Cognizant, Labcorp Drug Development, IQVIA, IQVIA, Parexel International Corporation, BioClinica Inc., Clinquest Inc.
View More On The Pharmacovigilance Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Key Pharmacovigilance Market Segments
The global pharmacovigilance market is segmented –
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users
Request A Sample Of The Global Pharmacovigilance Market Report 2023:
Pharmacovigilance is the science and practise of identifying, evaluating, comprehending, and mitigating side effects and other medical/vaccination-related difficulties. It is used to establish whether the benefits of a drug exceed the risks, and it does not cease once the pharmaceuticals are approved.
The Pharmacovigilance Global Market Report 2023 offers a comprehensive overview on the pharmacovigilance market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The Table Of Content For The Pharmacovigilance Market Include:
1. Pharmacovigilance Market Executive Summary
2. Pharmacovigilance Market Segments
3. Pharmacovigilance Market Size And Pharmacovigilance Market Growth Rate
4. Key Pharmacovigilance Market Trends
5. Major Pharmacovigilance Market Drivers
25. Key Mergers And Acquisitions In The Pharmacovigilance Market
26. Top Pharmacovigilance Companies
27. Pharmacovigilance Market Opportunities And Strategies
28. Pharmacovigilance Market, Conclusions And Recommendations
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model